About Doctor

lity of anato-metabolic imaging in brain tumors. This was a prospective study done during my
senior residency under the guidance of Dr.N.R. Datta, Professor of Radiation Oncology, SGPGIMS, Lucknow.
This paper was presented at the Annual conference of UP Chapter of Association of Radiation Oncologists of India
(AROI), Lucknow,2001.

Prevalence of Helicobacter pylori in patients with carcinoma stomach- Our Experience. This was a prospective study
done during my senior residency in Medical Oncology that analysed the prevalence of H.pylori among patients with
carcinoma stomach at Madras Medical College. This paper was presented at the XI Biennial Conference of Indian
Society of Oncology and XIII Biennial Conference of Indian Society of Medical & Pediatric Oncology at Bangalore 2004.

An INDOX case- control study ( Risk factors for breast cancer in India )

Prospective, multicenter, randomised,open label, two arm,parallel group, active control, comparative clinical study to
evaluate efficacy, safety and pharmacokinetics of R-TPR- 016/ XXX when give intravenously in patients with metastatic
HER -2 overexpressing Breast cancer.

A mutinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Drug X in the
prevention of venous thromboembolism in cancer patients at high risk for VTE and who are undergoing chemotherapy.

A study of Drug X in Combination with Paclitaxel plus Cisplatin in Advanced NSCLC

Phase II single-arm study of Drug X by 4-hr infusion in patients with recurring platinum-resistant ovarian cancer

A randomised phase II study comparing Drug X-pemetrexed, pemetrexed alone and Drug X alone as second line treatment for
non-smoker patients with locally advanced or metastatic NSCLC

A Multinational,Randomized,double- blind,placebo controlled study to evaluate the efficacy and safety of xxxxxx in the
prevention of Venous Thromboembolism(VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy
(protocol EFC6521)

A Phase II Study to Determine the Safety, Efficacy, and Pharmacokinetics of Multiple Intravenous Doses of Drug X 80 mg,
160 mg, and 320 mg Versus Placebo Administered to Patients with Non-Small Cell Lung Cancer-Related Fatigue and Cachexia

Phase II study to evaluate the safety, tolerability and efficacy of FOLFOX + Drug X versus FOLFOX alone administered
intravenously to patients with colorectal adenocarcinoma previously untreated for metastatic disease

A phase III study of Erbb2 Positive Advanced or Metastatic Gastric or Esophageal or Gastroesophageal junction
adenocarcinoma treated with capecitabine plus Oxaliplatin with or without Drug X

Prospective, multi-centric, randomized open-label, two-arm, parallel group, active-control, comparative clinical study to evaluate
efficacy, safety and pharmacokinetics of R-TPR-033 / ERBITUX® in patients with recurrent locoregional or metastatic squamous
Cell carcinoma of the head and neck.

MYL-Her3001-A multicenter, double-blind, randomized, parallel-group, phase III study of the efficacy and safety of Hercules
plus taxane versus Herceptin® plus taxane as first line therapy in patients with HER2-positive metastatic breast cancer

A Prospective, Multicenter, Observational Study Examining The clinical Utility Of Canscript In Routine Clinical Practice”.